Kirkland, WA) was recently issued a new United States patent pertaining to new methods and compounds for treating human amyloid diseases
, including Alzheimer's disease.
There is a growing list of amyloid diseases
, with over 25 different amyloid proteins identified (4).
The introduction of the inhibitor into a tau protein solution completely prevented amyloid fibre formation, validating the idea that the structure-based design of therapeutics for amyloid diseases
is a plausible option.
Scientists in California have found a way to prevent proteins from misfolding and thereby potentially prevent or at least arrest any one of hundreds of amyloid diseases
About ProteoTech: ProteoTech is a private drug development company in Kirkland, WA and is focused on targeting amyloid diseases
Professor Kelly said, ``The same approach may also work with other amyloid diseases
About ProteoTech: ProteoTech is a private drug development company located in the Seattle, WA area (Kirkland, WA), and is focused on targeting amyloid diseases
caused by protein misfolding.
About ProteoTech: ProteoTech is a private drug development Company founded in 1996 that is a world-leader in therapeutics targeting amyloid diseases
Exebryl-1(R) is a novel small molecule drug developed at ProteoTech from its unique library of small molecule compounds designed to target specific amyloid diseases
TTR misfolding is associated with a number of amyloid diseases
, which typically occur in patients aged 30 and above.
This patent covers a novel and highly effective method for rapid diagnostic testing of blood and other bodily fluids for the early detection of more than 40 amyloid diseases
such as Alzheimer's disease (AD), Creutzfeldt-Jakob disease (the human variant of "Mad Cow" disease), Parkinson's disease, Huntington's disease, systemic amyloidosis, diabetes and other diseases.